Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 13 studies | 31% ± 15% | |
oligodendrocyte | 13 studies | 34% ± 14% | |
adipocyte | 7 studies | 19% ± 2% | |
pericyte | 7 studies | 28% ± 5% | |
Mueller cell | 5 studies | 23% ± 5% | |
podocyte | 4 studies | 71% ± 18% | |
smooth muscle cell | 4 studies | 26% ± 12% | |
endothelial cell | 3 studies | 34% ± 6% | |
cardiac muscle cell | 3 studies | 23% ± 3% | |
retinal cone cell | 3 studies | 55% ± 17% | |
retinal rod cell | 3 studies | 48% ± 19% | |
mesothelial cell | 3 studies | 30% ± 10% | |
GABAergic neuron | 3 studies | 35% ± 3% | |
glutamatergic neuron | 3 studies | 35% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 16740.88 | 2642 / 2642 | 100% | 140.77 | 703 / 705 |
kidney | 91% | 8970.46 | 81 / 89 | 40% | 3.94 | 362 / 901 |
breast | 20% | 418.93 | 93 / 459 | 83% | 10.18 | 926 / 1118 |
thymus | 3% | 43.18 | 17 / 653 | 82% | 9.25 | 494 / 605 |
blood vessel | 78% | 2825.84 | 1036 / 1335 | 0% | 0 | 0 / 0 |
heart | 70% | 1817.64 | 606 / 861 | 0% | 0 | 0 / 0 |
skin | 11% | 194.42 | 193 / 1809 | 52% | 8.18 | 247 / 472 |
adrenal gland | 0% | 11.94 | 1 / 258 | 60% | 19.88 | 137 / 230 |
pancreas | 0% | 0 | 0 / 328 | 59% | 4.84 | 105 / 178 |
tonsil | 0% | 0 | 0 / 0 | 51% | 5.84 | 23 / 45 |
adipose | 33% | 1438.96 | 398 / 1204 | 0% | 0 | 0 / 0 |
lung | 1% | 16.14 | 5 / 578 | 31% | 2.19 | 359 / 1155 |
esophagus | 1% | 13.88 | 10 / 1445 | 26% | 1.84 | 48 / 183 |
uterus | 1% | 11.21 | 1 / 170 | 21% | 1.45 | 98 / 459 |
ovary | 0% | 0 | 0 / 180 | 20% | 1.17 | 84 / 430 |
prostate | 0% | 0 | 0 / 245 | 17% | 0.79 | 84 / 502 |
bladder | 0% | 0 | 0 / 21 | 12% | 0.77 | 60 / 504 |
eye | 0% | 0 | 0 / 0 | 11% | 0.96 | 9 / 80 |
liver | 0% | 0 | 0 / 226 | 10% | 0.86 | 39 / 406 |
intestine | 2% | 25.41 | 16 / 966 | 7% | 0.54 | 38 / 527 |
stomach | 0% | 0 | 0 / 359 | 7% | 0.29 | 19 / 286 |
spleen | 2% | 23.06 | 4 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0001525 | Biological process | angiogenesis |
GO_0051781 | Biological process | positive regulation of cell division |
GO_2000347 | Biological process | positive regulation of hepatocyte proliferation |
GO_0030324 | Biological process | lung development |
GO_1901509 | Biological process | regulation of endothelial tube morphogenesis |
GO_0001759 | Biological process | organ induction |
GO_0032148 | Biological process | activation of protein kinase B activity |
GO_0034605 | Biological process | cellular response to heat |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0007165 | Biological process | signal transduction |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_1902533 | Biological process | positive regulation of intracellular signal transduction |
GO_1903672 | Biological process | positive regulation of sprouting angiogenesis |
GO_0060681 | Biological process | branch elongation involved in ureteric bud branching |
GO_0042060 | Biological process | wound healing |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0072163 | Biological process | mesonephric epithelium development |
GO_0030154 | Biological process | cell differentiation |
GO_0030334 | Biological process | regulation of cell migration |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_2000544 | Biological process | regulation of endothelial cell chemotaxis to fibroblast growth factor |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0045542 | Biological process | positive regulation of cholesterol biosynthetic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008201 | Molecular function | heparin binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0005178 | Molecular function | integrin binding |
GO_0005104 | Molecular function | fibroblast growth factor receptor binding |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0044548 | Molecular function | S100 protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FGF1 |
Protein name | Fibroblast growth factor 1 Fibroblast growth factor 1 (FGF-1) (Acidic fibroblast growth factor) (aFGF) (Endothelial cell growth factor) (ECGF) (Heparin-binding growth factor 1) (HBGF-1) Alternative protein FGF1 |
Synonyms | FGFA |
Description | FUNCTION: Plays an important role in the regulation of cell survival, cell division, angiogenesis, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Acts as a ligand for FGFR1 and integrins. Binds to FGFR1 in the presence of heparin leading to FGFR1 dimerization and activation via sequential autophosphorylation on tyrosine residues which act as docking sites for interacting proteins, leading to the activation of several signaling cascades. Binds to integrin ITGAV:ITGB3. Its binding to integrin, subsequent ternary complex formation with integrin and FGFR1, and the recruitment of PTPN11 to the complex are essential for FGF1 signaling. Induces the phosphorylation and activation of FGFR1, FRS2, MAPK3/ERK1, MAPK1/ERK2 and AKT1 . Can induce angiogenesis . . |
Accessions | ENST00000419524.6 [P05230-1] ENST00000610990.4 [P05230-1] ENST00000407758.5 ENST00000621536.4 [P05230-1] C9JDC5 ENST00000394496.2 ENST00000337706.7 [P05230-1] ENST00000441680.6 [P05230-1] B5MCF4 L8ECL8 ENST00000612258.4 [P05230-1] P05230 ENST00000619447.4 [P05230-1] ENST00000378046.5 [P05230-1] ENST00000411960.1 ENST00000359370.10 [P05230-1] ENST00000360966.9 [P05230-2] C9JUP6 |